Please login to the form below

Not currently logged in
Email:
Password:

Cipla names Adil Zainulbhai to board

He has experience at consulting firm McKinsey & Company
Adil-Zainulbhai-Cipla

India-based pharma company Cipla has appointed Adil Zainulbhai to its board as an independent director.

A native of India Zainulbhai moved to the US in 1979 to join consulting firm McKinsey & Company. He returned to Mumbai in 2004 to help grow the company's presence in India, working with CEOs of many of the country's largest firms across several industries.

Cipla chairman Y K Hamied said: "Adil's 30 plus years of experience across various industries in India and globally will add a valuable perspective to our board of directors."

Zainulbhai said: "Cipla has had a huge impact in providing affordable pharmaceuticals to the world while building a strong company. I look forward to helping Cipla become even more successful."

29th July 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....